Chip Parkinson

Myriad Genetics has appointed Chip Parkinson as executive vice president for reimbursement strategy. He will report to President and CEO Mark Capone. Parkinson comes to Myriad from Cambia Health Solutions where he served as president of OmedRx and MedSavvy, and as chief pharmacy officer for Regence Blue Cross Blue Shield Health Plans. He has also served in general management and managed care leadership roles at Pfizer and Myriad.


Jason Flowerday

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.